About us

We are the global pioneers of mixed culture fermentation for the efficient and reliable production of complex novel biopharmaceuticals.

As showcase product, we envision ExCulture’s alternative heparin to be the preferred, safer, more efficacious product that not only solves the current shortage but altogether replaces the current animal-derived heparin in the US and Europe.

United by a shared vision to disrupt traditional bioprocessing methods, our team is dedicated to develop synthetic alternatives using our novel bioprocess fermentation technology that is more efficacious, safer, and environmentally sustainable.